Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Labcorp Holdings (LH) and Bruker (BRKR)

Tipranks - Tipranks - Thu Apr 9, 2:58AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on UnitedHealth (UNH), Labcorp Holdings (LH) and Bruker (BRKR).

Easter Sale - 70% Off TipRanks

UnitedHealth (UNH)

Wells Fargo analyst Stephen Baxter maintained a Buy rating on UnitedHealth yesterday and set a price target of $370.00. The company’s shares closed last Tuesday at $307.73.

According to TipRanks.com, Baxter is a 1-star analyst with an average return of -1.4% and a 42.6% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Concentra Group Holdings Parent, Inc., BrightSpring Health Services, Inc., and Molina Healthcare. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for UnitedHealth with a $365.95 average price target, a 18.5% upside from current levels. In a report issued on April 1, Raymond James also upgraded the stock to Buy with a $330.00 price target.

See the top stocks recommended by analysts >>

Labcorp Holdings (LH)

Bank of America Securities analyst Michael Ryskin maintained a Buy rating on Labcorp Holdings yesterday and set a price target of $295.00. The company’s shares closed last Tuesday at $269.17.

According to TipRanks.com, Ryskin is a 3-star analyst with an average return of 1.1% and a 47.3% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Caris Life Sciences, Inc., and Tempus AI, Inc. Class A. ;'>

Currently, the analyst consensus on Labcorp Holdings is a Strong Buy with an average price target of $306.13.

Bruker (BRKR)

Citi analyst Patrick B Donnelly maintained a Hold rating on Bruker yesterday and set a price target of $40.00. The company’s shares closed last Tuesday at $36.67.

According to TipRanks.com, Donnelly is a 3-star analyst with an average return of 1.1% and a 42.7% success rate. Donnelly covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Caris Life Sciences, Inc., and Fortrea Holdings Inc. ;'>

Bruker has an analyst consensus of Moderate Buy, with a price target consensus of $43.50, implying a 18.8% upside from current levels. In a report issued on March 24, TipRanks – xAI also reiterated a Hold rating on the stock with a $33.00 price target.

Read More on UNH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).